According to the publisher, Latin America gene editing technology market size is expected to record a CAGR of 7.7% during 2023-2027 to reach US$0.467 billion by 2027, increasing from US$0.323 billion in 2023. Over the last five years, the sector has recorded a CAGR of 9.0% to reach US$0.296 billion in 2022.
This offering is a bundled offering, combining 4 countries and a key report covering Latin America region. This report provides an in-depth data-centric analysis of the emerging opportunities in the gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application.
This offering is a bundled offering, combining 4 countries and a key report covering Latin America region. This report provides an in-depth data-centric analysis of the emerging opportunities in the gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application.
This title is a bundled offering, combining the following 5 reports, covering 175+ tables and 220+ figures:
- Country Report 1- Latin America Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 2- Brazil Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 3 - Argentina Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 4- Colombia Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 5- Mexico Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update
Scope
This report provides an in-depth, data-centric analysis of the Asia Pacific's gene editing market 2018-2027. Below is a summary of key market segments:By Technology
- CRISPR CAS 9
- TALENs
- ZFN
- Others (Meganucleases)
By CRISPR PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By TALENs PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By ZFNs PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By Meganucleases PRODUCTS
- Kits & Enzymes
- Cell lines & Antibodies
- Others (Plasmid, Controls)
By Delivery Method
- Ex-vivo
- In-vivo
By Disease/Disorders
- Cancer
- Blood Disorders (beta-thalassemia and sickle cell disease)
- Blindness
- Respiratory Disease (COVID-19 & Cystic fibrosis)
- Others (AIDS, Huntington’s disease, Muscular dystrophy)
By Application
- Drug Development
- Diagnostics
- Plant Gene Editing
- Others (Animal Gene Editing)
By End-User
- Pharmaceutical and Biopharmaceutical Companies
- Biotechnology Companies
- Contract Research Organisations
- Academic Institutes and Research Centres
Table of Contents
This title is a bundled offering, combining the following 5 reports, covering 175+ tables and 220+ figures:
1 About this report
3 Gene Editing Technology Market Size by Technology, 2018-2027
4 Gene Editing Technology Market Size by CRISPR Product, 2018-2027
5 Gene Editing Technology Market Size by TALENs Product, 2018-2027
6 Gene Editing Technology Market Size by ZFNs Product, 2018-2027
7 Gene Editing Technology Market Size by Meganucleases Product, 2018-2027
8 Gene Editing Technology Market Size by Delivery Mode, 2018-2027
9 Gene Editing Technology Market Size by Diseases/Disorders, 2018-2027
10 Gene Editing Technology Market Size by Application, 2018-2027
11 Gene Editing Technology Market Size by End Users, 2018-2027
12 Further Reading
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 300 |
| Published | August 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 0.32 Billion |
| Forecasted Market Value ( USD | $ 0.47 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Latin America |
